@curator

2 years ago

Article

FDA expands approval of Gilead's Veklury, providing young children their first COVID treatment option

Rating: 0.0

Likes: 1

Library: 1

FDA expands approval of Gilead's Veklury, providing young children their first COVID treatment option

Back in October 2020, Gilead's antiviral Veklury (remdesivir) became the first drug endorsed by the FDA for the treatment of COVID-19. | With the FDA's expansion of its approval for Gilead's Veklury, it has become the first COVID drug approved to treat children younger than age 12. The drug is approved for use in kids age 28 days and older who are hospitalized with COVID or are at risk for progression to a severe form of the virus.

Rate This Post

Rate The Educational Value

Rate The Ease of Understanding and Presentation

Interesting or Boring? Rate the Entertainment Value

FDA expands approval of Gilead's Veklury, providing young children their first COVID treatment option

Rate This Post

Related Topics

Comments

Media:

My Account:

Boostlane:

Select a Category

Topics Trending Today

Recommended Media

Boostlane Reward System

Unlocking the Power of Knowledge
for Humanity's Progress

Quick Links

Select a Locale

Unlocking the Power of Knowledge
for Humanity's Progress

FDA expands approval of Gilead's Veklury, providing young children their first COVID treatment option

Rate This Post

Related Topics

Comments

Media:

My Account:

Boostlane:

Select a Category

Topics Trending Today

Recommended Media

Boostlane Reward System

Unlocking the Power of Knowledge for Humanity's Progress

Quick Links

Select a Locale

Unlocking the Power of Knowledge for Humanity's Progress

Unlocking the Power of Knowledge
for Humanity's Progress

Unlocking the Power of Knowledge
for Humanity's Progress